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Minor sequence modifications 
in temporin B cause drastic 
changes in antibacterial potency 
and selectivity by fundamentally 
altering membrane activity
Giorgia Manzo1, Philip M. Ferguson1, V. Benjamin Gustilo1, Charlotte K. Hind2, 
Melanie Clifford2, Tam T. Bui3, Alex F. Drake3, R. Andrew Atkinson3, J. Mark Sutton2, 
Giovanna Batoni4, Christian D. Lorenz5, David A. Phoenix6 & A. James Mason  1
Antimicrobial peptides (AMPs) are a potential source of new molecules to counter the increase 
in antimicrobial resistant infections but a better understanding of their properties is required to 
understand their native function and for effective translation as therapeutics. Details of the mechanism 
of their interaction with the bacterial plasma membrane are desired since damage or penetration 
of this structure is considered essential for AMPs activity. Relatively modest modifications to AMPs 
primary sequence can induce substantial changes in potency and/or spectrum of activity but, hitherto, 
have not been predicted to substantially alter the mechanism of interaction with the bacterial plasma 
membrane. Here we use a combination of molecular dynamics simulations, circular dichroism, solid-
state NMR and patch clamp to investigate the extent to which temporin B and its analogues can be 
distinguished both in vitro and in silico on the basis of their interactions with model membranes. 
Enhancing the hydrophobicity of the N-terminus and cationicity of the C-terminus in temporin B 
improves its membrane activity and potency against both Gram-negative and Gram-positive bacteria. 
In contrast, enhancing the cationicity of the N-terminus abrogates its ability to trigger channel 
conductance and renders it ineffective against Gram-positive bacteria while nevertheless enhancing its 
potency against Escherichia coli. Our findings suggest even closely related AMPs may target the same 
bacterium with fundamentally differing mechanisms of action.
Antimicrobial peptides (AMPs) are a possible new source of antibiotic molecules and attract interest due to their 
multifaceted features which confer a broad spectrum of activity and low rate of resistance development1–3. AMPs 
have been isolated from almost all living forms, from bacteria to humans, where they act as a primary line of 
defence against pathogenic infections4–6. Often, a family of AMPs are found in each organism, sharing substantial 
primary sequence similarity and/or physical properties. It is generally accepted that the main factor determining 
the potency of AMPs is their interaction with the bacterial plasma membrane and that they kill pathogens by 
altering the permeation of the membrane and causing cell lysis1–3,7 or by crossing the membrane to interact with 
intracellular targets1,6,8. Damage of model membranes by AMPs is well documented, with alteration of membrane 
permeability by AMPs explained using a variety of hypothetical models which have been added to and/or refined 
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in recent years1,7. It has been assumed that AMPs that are closely related will interact with bacterial plasma mem-
branes with broadly similar mechanisms.
The most common approach adopted to improve the antimicrobial properties of native AMPs, involves the 
modification of the physicochemical properties of the peptide sequence, including the net positive charge, hydro-
phobicity, hydrophobic moment and potential to adopt helical conformation to balance antimicrobial activity 
and host cell toxicity9. Such studies often proceed on the basis that the overall mechanisms of bactericidal action 
are not expected to alter following minor sequence modifications but that the native function of the AMP is 
enhanced. Recently we have compared the mechanism of action of seemingly closely related AMPs from the 
same class and found substantial differences in both the bacterial response to challenge and the ability of each 
peptide to penetrate model membranes10,11. As a result, we hypothesised that even relatively minor alterations 
to the primary sequence of an AMP can result in fundamentally different behaviour when binding to models of 
the bacterial plasma membrane. The effects of an altered mechanism of action may be neutral but could lead to 
substantial changes in anti-bacterial potency and/or selectivity and may afford distinct native functions to even 
closely related AMPs from the same family.
To test our hypothesis, we report here our investigation of the effect of previously reported modifications 
to the sequence of temporin B on its ability to insert and disrupt model membranes and the effect this has on 
bactericidal activity against representatives of Gram-negative and Gram-positive pathogens. Temporin B (TB) 
belongs to the temporin family, one of the largest families of AMPs, whose members are closely related and 
were initially isolated from the skin mucus of the European common frog Rana temporaria12–14. Temporins are 
mainly active against Gram-positive bacteria, with minimal inhibitory concentration (MIC) values ranging from 
2.5–20 µM13,14. They are less active against Gram-negative bacteria, with the exception of temporin L, which 
showed MIC ranging from 2–20 µM13,15. Temporin B L1FK and temporin B KKG6A are two analogues derived 
from the temporin B sequence, designed to improve activity against Gram-negative bacteria. Temporin B L1FK 
was obtained from a computational statistical model designed to predict the toxicity of the peptide as well as the 
antimicrobial activity. Temporin B L1FK maintains the physicochemical properties of the native peptide, such as 
hydrophobicity and amphipathic profile, but it has a broader spectrum of activity at low concentration, including 
against Gram-negative bacteria, as well as a higher potency in eradication of biofilms16,17. Temporin B KKG6A 
was instead obtained by further optimization of an analogue obtained through alanine scanning of the temporin 
B sequence. The properties of temporin B KKG6A differ from temporin B, with a higher positive charge, a dif-
ferent amphipathic profile and a higher helical content, but is reported to have improved antimicrobial activity 
against Gram-negative and Gram-positive bacteria, a low haemolytic activity and a strong tendency to bind to 
lipopolysaccharide16,18.
To distinguish between the mode of interaction of the three temporin B analogues we combined both 
time-resolved and steady-state biophysical methods including all atom molecular dynamics simulations (using 
NMR structures of the three temporin B peptides solved in anionic detergent as a starting point), with circular 
dichroism and solid-state NMR to determine conformational and topological differences during the initial stages 
of membrane interaction and in the steady-state. In addition, electrophysiology measurements of the current 
transitions on model membranes obtained with the patch-clamp technique reveal how these impact on the ability 
of each peptide to permeate analogous model membranes and enable understanding of the antibacterial outcome.
Experimental procedures
Materials. Peptides (Table 1) were purchased from Pepceuticals (Enderby, UK) and Cambridge Research 
Biochemicals (Cleveland, UK) as desalted grade and were further purified using water/acetonitrile gradients 
using a Waters SymmetryPrep C8, 7 mm, 19 × 300 mm column. They were all amidated at the C-terminus. The 
lipids 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1′-rac-glycerol) (POPG), 1-palmitoyld31-2-oleoyl-sn-glycero-
3-phospho-(1′-rac-glycerol) (POPG-d31), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (POPE), 
1-palmitoyld31-2-oleoyl-sn-glycero-3-phosphoethanolamine (POPE-d31), 1,2-diphytanoyl-sn-glycero-
3-phospho-(1′-rac-glycerol) (DPhPG) and 1,2-diphytanoyl-sn-glycero-3-phosphoethanolamine (DPhPE) were 
purchased from Avanti Polar Lipids, Inc. (Alabaster, AL) and used without any purification. All other reagents 
were used as analytical grade or better.
Antibacterial activity assay. The antibacterial activity of the peptides studied was assessed through a mod-
ified two-fold broth microdilution assay, as described before10. Briefly, a two-fold dilution of peptide stock solu-
tions was performed in either non-cation adjusted Müller-Hinton broth (MHB) or Tryptic Soy broth (TSB) in a 
96-well polypropylene microtiter plate. Then, 100 µl of bacterial suspension (back diluted from overnight cultures 
to an A600 of 0.01) were added to 100 µl of peptide solution in each well of the plate. Growth and sterility controls 
were present for each experiment. The plate was incubated at 37 °C for 18 hours without shaking and the MIC 
was defined as the lowest concentration where no visible growth could be detected by measuring the absorbance 
(A600) on an Omega plate reader.
NMR spectroscopy and structure determination. Liquid state NMR spectroscopy experiments and 
data analysis were performed as described before11. The samples solution consisted of 2 mM peptide and 100 mM 
deuterated sodium dodecyl sulphate (SDS-d25) micelles. 10% D2O containing trimethylsilyl propanoic acid (TSP) 
was added for the lock signal and as internal chemical shift reference. NMR spectra were acquired on a Bruker 
Avance 500 MHz spectrometer (Bruker, Coventry, UK) equipped with a cryoprobe. Standard Bruker TOCSY 
and NOESY pulse sequences were used, with water suppression using an excitation sculping sequence with gra-
dients (mlevesgpph and noesyesgpph). The 1H 90-degree pulse length was 8.0 s. One TOCSY with a mixing time 
of 60 ms, and two NOESY with mixing time of 100 and 200 ms were acquired for each sample. The relaxation 
www.nature.com/scientificreports/
3Scientific RepoRts |          (2019) 9:1385  | https://doi.org/10.1038/s41598-018-37630-3
delay was 1 s. 2048 data points were recorded in the direct dimension, and either 256 or 512 data points in the 
indirect dimension. CARA (version 1.9.1.2) and Dynamo software19,20 were used for the structure calculation. 
Inter-proton NOEs interactions were used as distance restraints in the structure calculation. CARA software 
generated a total of 200 structures on UNIO’08 (version 1.0.4)21 and XPLOR-NIH (version 2.40)22,23, after 7 iter-
ations, using the software’s simulated annealing protocol. 20 structures with the lowest energy were chosen to 
produce a final average structure. In the case of ambiguous NOEs assignments by CARA software, Dynamo 
software’s annealing protocol was applied. Only unambiguous NOEs were used in this case after being classified 
as strong, medium and weak on the base of the relative intensity of the cross-peaks in the NOESY spectra. On the 
base of this classification an upper limit of 0.27, 0.33 and 0.50 nm have been applied, respectively, as restraint on 
the corresponding inter-proton distance, as described previously24. One thousand structures were calculated and 
the 100 conformers with the lowest potential energy were selected for the analysis. The selected 100 conform-
ers were aligned, and the root mean square deviation (RMSD) of the backbone heavy atoms was calculate with 
respect to their average structure. The conformer with the lowest RMSD was chosen as the starting structure for 
the MD simulations (see below). Solvent molecules were not included in the calculations. Structural coordinates 
and chemical shift tables were deposited in the Protein Data Bank (PDB; www.rcsb.org) and Biological Magnetic 
Resonance Bank (BMRB; www.bmrb.wisc.edu) respectively under accession codes 6GIL, 6GIK and 6GIJ (PDB) 
and 34274, 34273 and 34272 (BMRB) for temporin B, temporin B L1FK and temporin B KKG6A respectively. 
Details of structural validation can be found in the PDB.
Molecular dynamic simulations. Simulations were carried out on either a Dell Precision quad core T3400 
or T3500 workstation with a 1 kW Power supply (PSU) and two NVIDA PNY GeForce GTX570 or GTX580 
graphics cards using Gromacs25. The CHARMM36 all-atom force field was used in all simulations26,27. The ini-
tial bilayer configuration was built using CHARMM-GUI28. All membranes in this project contained a total of 
512 lipids, composed either of POPE/POPG (75:25 mol:mol) or POPG to reflect the lipid charge ratios of the 
plasma membrane of Gram-negative and Gram-positive bacteria, respectively. Eight peptides were inserted at 
least 30 Angstrom above the lipid bilayer in a random position and orientation at least 20 Angstrom apart. The 
starting structures were copies of the same conformer obtained from the NMR calculation in SDS micelles. The 
system was solvated with TIP3P water and Na+ ions added to neutralize. Energy minimization was carried out 
at 310 K with the Nose-Hoover thermostat using the steepest descent algorithm until the maximum force was 
less than 1000.0 kJ/ml/nm (~3000–4000 steps). Equilibration was carried out using the NVT ensemble for 100 ps 
and then the NPT ensemble for 1000 ps with position restraints on the peptides. Hydrogen bond angles were 
constrained with the Lincs algorithm. Final simulations were run in the NPT ensemble using 2 femtosecond 
intervals, with trajectories recorded every 2 picoseconds. All simulations were run for a total of 100 nanoseconds 
and repeated twice, with peptides inserted at different positions and orientations, giving a total of approximately 
1.2 ms simulation.
Liposomes preparation. Small unilamellar vesicles (SUVs) and multi-lamellar vesicles (MLVs) were 
prepared for circular dichroism (CD) and solid-state NMR (ssNMR) spectroscopy, respectively, and pre-
pared as previously described11. In both cases, lipids powders were solubilized in chloroform and dried under 
rotor-evaporation. To completely remove the organic solvent, the lipid films were left overnight under vacuum 
and hydrate in 5 mM Tris buffer with or without the addition of 100 mM NaCl (pH 7.0). Lipid suspension was 
subjected to 5 rapid freeze-thaw cycles for further sample homogenisation.
For ssNMR POPE/POPG-d31 (75:25, mol:mol), POPE/POPE-d31/POPG (50:25:25, mol:mol) and POPG/
POPG-d31 (75:25, mol:mol) were used to prepare the vesicles. MLVs obtained were centrifuged at 21000 g for 
30 minutes at room temperature and then pellets were transferred to Bruker 4 mm rotors for NMR measurements. 
Peptides were added to the buffer at a final concentration of 2% by mol, relative to lipids. POPE/POPG (75:25, 
mol:mol) and POPG SUVs were obtained by sonicating the lipid suspension on Soniprep 150 (Measuring and 
Scientific Equipment, London, UK) for 3 × 7 minutes with amplitude of 6 microns in the presence of ice to avoid 
lipid degradation. The SUVs were stored at 4 °C and used within 5 days from preparation.
Circular dichroism spectroscopy. Far-UV spectra of the peptides in the presence of SUVs and SDS 
micelles were acquired on a Chirascan Plus spectrometer (Applied Photophysics, Leatherhead, UK). Liposome 
samples were maintained at 310 K. Spectra were recorded from 260 to 190 nm. Lipid suspension was added to 
a 0.5 mm cuvette at a final concentration of 5.0 mM and then a few μl of a concentrated peptide solution were 
added and thoroughly mixed to give the indicated final peptide-to-lipid molar ratios. The same experimental 
conditions were used to investigate peptides secondary structure in SDS micelles. Final peptide concentration in 
the 0.5 mm cuvette was 40 µM, while SDS micelles concentration was 2 mM (L/P = 50). In processing, a spectrum 
Peptide Sequence Length Charge H μH
Peptide concentration (µM)
DPhPE/DPhPG DPhPG
Temporin B LLPIVGNLLK SLL 13 +2 0.947 0.601 25.34 35
Temporin B L1FK FLPIVGLLKS LLK 13 +3 0.924 0.548 11.32 4.94
Temporin B KKG6A KKLLPIVANL LKSLL 15 +4 0.709 0.600 200 100
Table 1. Peptides sequences, biophysical characteristics and concentration of peptide necessary to start 
membrane activity in electrophysiology experiments. All peptides were amidated at the C-terminus. 
Hydrophobicity (H) and hydrophobic moment (µH) were calculated using HeliQuest88.
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of the peptide free suspension was subtracted and Savitsky-Golay smoothing with a convolution width of 5 points 
applied.
Solid state 2H-NMR. 2H quadrupole echo experiments29 were performed at 61.46 MHz on a Bruker Avance 
400 NMR spectrometer using a 4 mm MAS probe, spectral width of 100 KHz and with recycle delay, echo 
delay, acquisition time and 90° pulse lengths of 0.25 s, 100 μs, 2.6 ms and 3 μs respectively. The temperature 
was maintained at 310 K to keep the bilayers in their liquid-crystalline phase. During processing the first 10 
points were removed in order to start Fourier-transformation at the beginning of the echo. Spectra were zero 
filled to 1 k points and 50 Hz exponential line-broadening was applied. Smoothed deuterium order parameter 
profiles were obtained from symmetrised and dePaked 2H-NMR powder spectra of POPG-d31 using published 
procedures30–32.
Electrophysiology experiments (Patch-clamp). Giant unilamellar vesicles (GUVs) composed of 
DPhPE/DPhPG (60:40, mol:mol) and DPhPG were prepared in the presence of 1 M sorbitol by electroformation 
method in an indium-tin oxide (ITO) coated glass chamber connected to the Nanion Vesicle Prep Pro setup 
(Nanion Technologies GmbH, Munich, Germany) using a 3-V peak-to-peak AC voltage at a frequency of 5 Hz 
for 120 and 140 minutes, respectively, at 36 °C33–35. Bilayers were formed by adding the GUVs solution to a buffer 
containing 250 mM KCl, 50 mM MgCl2 and 10 mM HEPES (pH 7.00) onto an aperture in a borosilicate chip 
(Port-a-Patch®; Nanion Technologies) and applying 70–90 mbar negative pressure resulting in a solvent-free 
membrane with a resistance in the GΩ range. After formation, a small amount of peptide stock solution (in 
water) was added to 50 µL of buffer solution in order to obtain its active concentration. All the experiments were 
carried on with a positive holding potential of 50 mV. The active concentration, the concentration at which the 
peptide first showed membrane activity, for each peptide was obtained through a titration performed in the same 
conditions. For all the experiments a minimum of 6 according repeats was done. Current traces were recorded at 
a sampling rate of 50 kHz using an EPC-10 amplifier from HEKA Elektronik (Lambrecht, Germany). The system 
was computer controlled by the PatchControl™ software (Nanion) and GePulse (Michael Pusch, Genoa, Italy, 
http://www.ge.cnr.it/ICB/conti_moran_pusch/programs-pusch/software-mik.htm). The data were filtered using 
the built-in Bessel filter of the EPC-10 at a cut-off frequency of 10 kHz. The experiments were performed at room 
temperature. Data analysis was performed with the pClamp 10 software package (Axon Instruments).
Results
Primary sequence and antibacterial activity. Comparison of the primary sequences of temporin B 
(TB) and its two analogues, temporin B L1FK and temporin B KKG6A indicates the extent of the modifications 
to the primary sequence and their effects on nominal charge, hydrophobicity (H) and hydrophobic moment 
(µH), assuming each peptide adopts an idealised α-helix (Table 1). All three temporin B peptides are relatively 
hydrophobic and short and even single amino acid substitutions will be expected to have some impact on the 
physicochemical properties. Temporin B L1FK and temporin B KKG6A were both designed16,18 to enhance the 
activity of temporin B. For temporin B L1FK, the optimization involved the substitution of Leu1 with Phe1 to 
render the N-terminus more hydrophobic, the addition of a lysine residue at the C-terminus and the deletion 
of Asn716. Compared with the parent peptide, these modifications led to an increase in potency, albeit modest 
for Pseudomonas aeruginosa, for all species (Table 2). The activity of Temporin B L1FK was greater against both 
Gram-positive and Gram-negative bacterial isolates and against a Candida albicans isolate, and the increased 
potency to Klebsiella pneumoniae suggests the L1FK temporin B analogue can be considered a broader spec-
trum AMP than its parent peptide. To create temporin B KKG6A, two lysines are added to the N-terminus, 
increasing the nominal positive charge, and Gly6 is substituted with alanine18. These modifications improved 
the activity of the peptide against E. coli NCTC 12923 (a four-fold improvement in potency) and Acinetobacter 
baumanii in MHB, but the peptide loses activity against all Gram-positive isolates. Temporin KKG6A is more 
potent than its parent peptide but has a narrow spectrum of activity. The activity of the three temporin B peptides 
was modest against Pseudomonas aeruginosa, notably however the potency of temporin B KKG6A was greater 
when susceptibility testing was performed in TSB when compared with MHB. While the results reported here 
for temporin B L1FK are mostly in agreement with those reported previously16, those for temporin B KKG6A 
are in disagreement. Although the enhancement in activity against E. coli is consistent, an up to 8-fold improve-
ment in the activity against Gram-positive bacteria16,18 and 16-fold against P. aeruginosa16 was reported for tem-
porin KKG6A when compared to temporin B. Temporin B L1FK was also reported previously to have greater 
potency against P. aeruginosa16. Different protocols were applied in the previous studies, notably the use of TSB 
for culturing bacteria and challenges performed in sodium-phosphate buffer16, or culture in TSB or Luria Bertani 
broth followed by transfer to MHB and a 1.6 fold dilution by distilled water18. It has been shown recently that 
the choice of media can substantially alter the result of antibacterial susceptibility testing36,37 and we show here 
that, while use of TSB often led to higher MICs being reported, in the case of P. aeruginosa PAO1 the potency of 
temporin B KKG6A is increased to the point that an MIC is established whereas in MHB no activity is detectable 
(Table 2). When cultured in TSB, P. aeruginosa PAO1 is susceptible to temporin KKG6A and 50 µM peptide is 
sufficient, in vitro, to downregulate the pro-inflammatory chemokines and cytokines interleukin (IL)-8, IL-1β, 
IL-6 and TNF-α, produced downstream by P. aeruginosa infected human bronchial epithelial cells38. The ability 
of either temporin B L1FK or temporin B KKG6A to function in vivo is as yet unknown and hence it is yet to 
be established which in vitro susceptibility testing protocols are predictive of a therapeutic effect for this class of 
AMP. Nevertheless, the present antibacterial susceptibility testing indicates that relatively small changes in the 
primary sequence can have substantial impacts on antimicrobial activity, that the spectrum of activity is altered 
and, further, that these impacts cannot be easily related to changes in physicochemical properties such as nominal 
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charge or hydrophobicity. Distinct mechanisms and specific effects related to the peptide conformation or ability 
to effectively penetrate membranes can be suspected.
Conformation and structure of temporin B peptides in sodium dodecyl sulphate (SDS) micelles 
and in model membranes in the steady state. As a first step, the secondary structures of the three 
temporin B peptides were initially analysed and characterised with far-UV CD and NMR spectroscopy in the 
presence of SDS micelles to mimic the negative surface of a bacterial membrane (Figs 1 and S1). Structures for 
temporin B and temporin B KKG6A have been solved previously in LPS micelles18,39 and in the presence of E. 
coli and Staphylococcus epidermidis cells40,41 although coordinates are not available in the Protein Data Bank. 
Temporin B KKG6A adopts a more extended double β-turn (~40% of the whole sequence) in the -IVANLK- 
region. In all three peptides there is little evidence of order from the N-terminus to the glycine residue (temporin 
B and temporin B L1FK) or from the N-terminus to the proline residue (temporin B KKG6A). The structure of 
temporin B KKG6A is consistent with that described in the presence of LPS micelles and E. coli cells where an 
ordered α-helix extends from Pro5 until the C-terminus with the N-terminus largely disordered18,40. In support, 
the far-UV CD spectra indicate that the Ramachandran angles adopted by the ordered regions of the peptides 
are similar to those of an α-helix and hence an α-helix like spectrum. The greater magnitude of the temporin B 
KKG6A CD spectrum compared with the temporin B CD spectrum reflects the increase from ~27% to ~40% 
whole molecule order. In contrast, the CD spectrum of temporin L1FK is more compatible with the extended 
α-helix often found in membrane proteins located in membranes as opposed to just water42. These results are in 
broad agreement with the predicted effects of the design of temporin B L1FK16 where the aim was to largely retain 
the physicochemical properties of the ancestor peptide.
As more realistic models of the plasma membrane in Gram-negative and Gram-positive bacteria respectively, 
the conformation of the peptides in lipid bilayers, composed of either POPE/POPG (75:25 mol:mol) or POPG 
only, was investigated in the steady state through far-UV CD spectroscopy (Fig. S2). Small amounts of pep-
tide stock solution were added to small unilamellar vesicles (SUVs) to decrease the lipid-to-peptide ratio and 
investigate the effect of peptide concentration on the secondary structure. Measurements were performed in the 
presence of 100 mM NaCl, to maintain as similar environment as possible to those used for other experimental 
procedures. All three peptides adopted a disordered structure when in buffered solution and adopted ordered 
conformations, of the type described for temporin B KKG6A in SDS. The titration indicates that all peptide mol-
ecules in solution bind to the vesicles. A notable exception in the series is illustrated for temporin B itself in the 
presence of POPE/POPG (75/25) and POPG, with a less pronounced negative 220 nm feature which indicates a 
more ordered tail or a less ordered β-turn (Fig. S2A,D). Otherwise, differences are small and the CD spectra can 
be said to be broadly similar.
MD simulations reveal different conformational flexibilities on initial binding to model membranes. 
To characterise the interaction of temporin B analogues with model membranes with atomic resolution, duplicate 
all atom simulations were run for 100 ns. In each case, using the structures determined by NMR in SDS for the 
starting configuration, eight peptides for each temporin B analogue were placed in water above bilayers compris-
ing either 512 POPG lipids or a mixture of 384 POPE and 128 POPG lipids.
Averaged psi dihedral angles for each residue in the eight temporin B peptides are similar in the presence 
of both POPE/POPG and POPG (Figs 2A,B and S3A,B) membranes; as in previous work11, phi dihedral angles 







MHB TSB MHB TSB MHB TSB
Gram-negative
Klebsiella pneumoniae NCTC 13368 128 >128 128 >128 32 128
Klebsiella pneumoniae M6 128 >128 128 >128 32 64
Acinetobacter baumanii AYE 32 64 32 64 8 8
Acinetobacter baumanii ATCC 17978 64 128 32 64 8 16
Pseudomonas aeruginosa PAO1 >128 >128 >128 128 128 128
Pseudomonas aeruginosa NCTC 13437 128 >128 >128 >128 128 >128
Escherichia coli NCTC 12923 64 128 16 64 8 64
Gram-positive
MS Staphylococcus aureus NCTC 6571 16 16 128 >128 4 8
EMR Staphylococcus aureus−15 NCTC 13616 16 64 >128 >128 16 16
EMR Staphylococcus aureus-16 NCTC 13277 32 32 >128 >128 16 16
VS Enterococcus faecalis NCTC 775 64 128 >128 >128 32 64
VR Enterococcus faecalis NCTC 12201 64 >128 >128 >128 64 128
Fungus Candida albicans NCPF 3179 32 128 64 128 16 64
Table 2. Antimicrobial activity. MS – methicillin sensitive; EMR – epidemic methicillin resistant; VS – 
vancomycin sensitive; VR – vancomycin resistant; MH – Müller-Hinton broth; TSB – tryptic soy broth. Data 
in bold indicates a four-fold or more increase in MIC or a MIC becoming undetectable according to change in 
media used.
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accepted for α-helix conformations but instead correspond to more extended conformations43. Temporin B dis-
plays considerable conformational flexibility during these first 100 ns which increases from N- to C-terminus. 
Modifications made to generate temporin B L1FK have a noticeable impact on the preferred conformation 
adopted in both membrane types; the deletion of Asn7, such that Leu7 now follows Gly6, induces a shift in local 
conformation with psi angles for residues 6–8 (GLL) consistent with the β-turn (single turn α-helix) confor-
mation (Figs 2C,D and S3C,D). The conformational flexibility of temporin B is however retained throughout 
the length of the modified peptide. The modifications made to generate temporin B KKG6A have a much more 
substantial impact. Except for the five residues at the N-terminus, there is a shift in psi angles associated with 
the replacement of a glycine (Gly6 in temporin B) with alanine (Ala9 in temporin B KKG6A) such that residues 
6–12 (PIVANLK) adopt a two turn α-helix conformation (Figs 2E,F and S3E,F). Conformational flexibility is also 
reduced throughout the length of the peptide with only the two residues at the C-terminus unaffected.
Modification of temporin B affects its penetration of lipid bilayers and aggregation at their surface. 
In addition to changes in preferred secondary structure, MD simulations allow visualisation of the ability of 
the three temporin B peptides to penetrate either POPE/POPG or POPG bilayers (Figs 3 and S4). All peptides 
start the simulation in water with no contact with the membrane. After the simulation had run for 100 ns all 
the peptides were interacting with the lipids regardless of the composition of the membrane. In general, the 
temporin B peptides showed deeper insertion in POPG membranes, as observed previously44, compared with 
POPE/POPG membranes. Contact and insertion began at the N-terminus in all cases as has been observed for 
other AMPs including temporin L, aurein 2.5, cecropin B and and pandinin 245–47. The temporin B peptides were 
also frequently self-associated (Figs 4 and S5) and assembled as dimers, trimers or even tetramers (Figs S6–11). 
Aggregation was consistently lower in POPG membranes compared with POPE/POPG membranes. Temporin B 
Figure 1. Three-dimensional structure for the three temporin B analogues. Structures were determined through 
1H-NOESY NMR spectroscopy in SDS-d25 micelles (peptide/detergent equal to 1/50). The structure with 
the minimum RMSD is shown and was used as starting point in the MD simulations. The hydrophobic and 
hydrophilic residues are shown in yellow and blue respectively for temporin B (A) temporin B L1FK (B) and 
temporin B KKG6A (C). CD spectra of the AMPs in the same conditions used for NMR experiments are shown in 
(E). NMR and CD spectroscopy both revealed a lower propensity in helical folding for temporin B and temporin B 
L1FK peptides. NMR structures were used as starting configurations for MD simulations of model membranes.
www.nature.com/scientificreports/
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is known to act in synergy with temporin L with the latter acting to inhibit the aggregation of the former48. Acting 
alone, temporin B struggles to penetrate far into POPE/POPG membranes, with residues 1–7 only inserting 
and these reaching only the interfacial region of the bilayer (Figs 3A and S4), with most peptides residing in an 
aggregated state (Figs 4A and S6). In POPG membranes the aggregation of temporin B is much less pronounced 
(Fig. 4B) and penetration proceeds more rapidly, is deeper – beginning to enter the hydrophobic core - and more 
of each peptide becomes buried (Figs 3B and S7).
Temporin B L1FK behaves similarly to temporin B (Figs 3C,D, 4C,D, S4C,D and S5C,D). However, its initial 
binding and the insertion were more effective than observed for the parent peptide. Temporin B L1FK inserted 
almost flat in both lipid compositions enabling more of the peptide to be buried (Figs 3C,D and S4C,D) and, 
notably in POPE/POPG, had a much lower tendency to self-associate than temporin B (Figs 4A,C and S5A,C). 
Again, in POPG bilayers the tendency to self-associate is reduced (Fig. 4D) and penetration into the hydrophobic 
interior of the membrane is greater than in POPE/POPG bilayers (Figs 3D and S8 and 9).
In contrast with temporin B and temporin B L1FK, temporin B KKG6A fails to insert into either bilayer 
beyond the first two residues of the N-terminus (Figs 3E,F and S4E,F). The result of additional positive charges at 
the N-terminus, the greater proportion of α-helix conformation and the reduced conformational disorder is that 
temporin B KKG6A has a much lower tendency to form higher order aggregates in either membrane, though may 
still form dimers and trimers (Figs S10 and 11). Penetration mediated by the previously hydrophobic N-terminus 
is halted by interactions between the two lysines and anionic lipid headgroups.
Figure 2. Secondary structure analysis of temporin B peptides from MD simulations in model membranes. 
Dihedral angles (psi) and their circular variance are shown for each residue averaged over 100 ns of simulation 
and eight peptides in temporin B (A,B), temporin B L1FK (C,D) and temporin B KKG6A (E,F) peptides when 
binding to POPE/POPG (A,C,E) or POPG (B,D,F) membranes.
www.nature.com/scientificreports/
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Peptide effects on membrane order. The relative differences in the ability of the temporin B peptides 
to penetrate lipid bilayers is expected to impact on their ability to disorder, disrupt or permeate membranes. 
In the MD simulations described above, temporin B and temporin B KKG6A had a greater tendency to cluster 
POPG lipids in mixed membranes (Fig. 5A). This could be related either to the greater nominal positive charge 
of temporin B KKG6A relative to temporin B (Table 1) or to the inability of both temporin B and temporin B 
KKG6A to penetrate easily beyond the interfacial region such that cationic residues remain concentrated at the 
bilayer surface and induce lateral separation of anionic and zwitterionic lipids. The interaction of cationic AMPs 
with anionic lipids has been demonstrated previously, in vitro11,49,50 and in silico11,51,52 to induce disordering of the 
lipid acyl chain and is associated with antimicrobial activity. Here, a good qualitative comparison was observed 
between the peptide induced membrane disordering obtained experimentally, in the steady-state, using 2H solid 
state NMR (Fig. 5B–D) and from disordering of lipids determined to be within a 4 Å ring of each peptide in MD 
simulations (Fig. S12).
In the steady-state, the average difference (ΔSCD) between the order parameter in the presence and absence 
of 2 mol% of each temporin B peptide on the POPG-d31 (Fig. 5B) and POPE-d31 (Fig. 5C) component in POPE/
POPG membranes and POPG-d31 in POPG membranes (Fig. 5D) allows comparison of any differing ability 
to disorder different components of each membrane (2H echo NMR spectra are available in the supplementary 
material (Fig. S13)). Notably, temporin B L1FK has a significantly (p < 0.05) greater disordering effect on the 
anionic component in mixed membranes than temporin B KKG6A (Fig. 5B) while the latter has a greater disor-
dering effect on the zwitterionic POPE when compared with both temporin B and temporin B L1FK (p < 0.05) 
(Fig. 5C). No effect of any of the three peptides can be detected on the order parameter for POPG-d31 in POPG 
Figure 3. Temporin B peptide topology during 100 ns MD simulation in model membranes. The depth of 
temporin B (A,B), temporin B L1FK (C,D) and temporin B KKG6A (E,F) insertion is shown as the Z-position 
relative to the phosphate group for each residue averaged over all eight peptides in each simulation. Positive 
or negative values indicate the peptides are below or above the phosphate group, respectively for peptides in 
POPE/POPG (A,C,E) or POPG (B,D,F).
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membranes (Fig. 5D) though the measured order parameter here is more likely to be reporting on an average of 
those lipids interacting with the peptides and those located in the remaining bulk than in the analogous experi-
ments on mixed POPE/POPG-d31 membranes where a higher probability of the labelled anionic lipid associating 
with cationic AMP is expected.
Temporin B analogues have drastically different abilities to induce conductance activity in model 
membranes. The whole-cell patch-clamp technique allows the measurements of current transitions on a 
phospholipid membrane. It has been largely used to study conductance and kinetics of membrane channels in 
cells and in lipid bilayers53. The recent development of the Port-a-Patch® automated patch-clamp system from 
Nanion Technologies (Munich, Germany), enables rapid testing of membrane active molecules with an auto-
mated system, bringing this technique into the drug discovery pipeline54–56. Previous works have applied this 
technique to investigate the mode of action of AMPs57–64. In particular, the three main membrane-activity models 
described in the introduction can be distinguished57. This protocol involved the use of a microperfusion sys-
tem on a standard pipette patch-clamp set up and mammalian cells57. We report here that the same aim was 
achieved with the Port-a-Patch® system and the use of model membranes, which enabled the peptides to be 
distinguished on the basis of their disruption of either DPhPE:DPhPG (60:40 mol:mol) or DPhPG bilayers, mim-
icking Gram-negative and Gram-positive bacteria, respectively65–69. Diphytanyl chains are used here since mem-
branes composed of these lipids are in a fluid phase at room temperature, irrespective of headgroup.
The membrane activity of the peptides can be distinguished on the basis of (1) the concentration required 
for membrane activity to be recorded (Tables 1), (2) the latency – the time taken for conductance to begin after 
Figure 4. Temporin B peptides aggregation during 100 ns MD simulation in model membranes. The 
probability of temporin B (A,B), temporin B L1FK (C,D) and temporin B KKG6A (E,F) aggregation is reported 
as frequency histogram of the Cα-Cα distances, respectively for peptides in POPE/POPG (A,C,E) or POPG 
(B,D,F) membranes.
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addition of peptide, (3) the duration of conductance activity, (4) the amplitude and number of each conductance 
event and (5) whether the AMP ultimately caused the membrane to break. The concentration used for the exper-
iments for each peptide is the minimum concentration necessary to observe activity and was obtained with a 
peptide titration of the model membrane (Table 1). Notably there is an apparent relationship between the ability 
of each temporin B peptide to insert rapidly into model membranes, as determined by the MD simulations, and 
the concentration required to induce conductance. Less than half as much temporin B L1FK as temporin B was 
required to induce conductance in DPhPE/DPhPG membranes while approximately seven times more temporin 
B than temporin B L1FK is required to induce conductance in DPhPG membranes. Temporin B KKG6A, for 
which no more than the two N-terminal residues penetrated either POPE/POPG or POPG bilayers, required 
nearly eighteen and over twenty times as much peptide as temporin B L1FK to induce conductance in, respec-
tively, DPhPE/DPhPG and DPhPG membranes.
Characteristic channel like activity - well-defined events with discrete opening levels – has been observed 
previously by others for alamethicin, gramicidin A, cecropin B and dermicidin58–60 and for other peptides in our 
hands. However, temporin B presented an irregular activity in both mixed and negatively charged membranes 
(Fig. 6A,B). Temporin B caused a perturbation of the membrane characterized by bursts of current (fast events 
seen mostly as spikes) with a wide distribution of amplitudes, ultimately resulting in a destabilization of the 
membrane. Interestingly, temporin B activity started relatively soon after peptide addition, always causing an 
immediate rupture of the membrane (Fig. 7).
Conductance induced by temporin B L1FK was also unaffected by membrane composition. Temporin B L1FK 
acted more slowly than temporin B (significantly so in DPhPG; p < 0.05) and induced a mixture of membrane 
activities, characterised by some channel-like events, with defined levels of amplitude, and irregular, fast events, 
similar to those induced by temporin B (Fig. 6C). In DPhPG, more pore-like events were visible, however the 
distribution of the opening and closing levels was broad and no single populations could be defined (Fig. 6D). 
Temporin B L1FK often broke DPhPE/DPhPG membranes, while it rarely broke DPhPG membranes (Fig. 7C,D), 
perhaps since conductance was achieved with a lower active concentration.
Membrane conductance induced by temporin B KKG6A was not detectable by electrophysiology unless a 
high concentration was reached. At these high concentrations, considerable destabilization of the membrane 
is observed with more numerous high amplitude events than observed for temporin B, particularly in DPhPG 
(Fig. 6E,F). Although conductance appears relatively soon after temporin B KKG6A addition, the membrane 
Figure 5. The effect of temporin B peptides on lipids. Capability of the peptides to cluster anionic lipids in 
POPE/POPG (75:25 mol:mol) membranes in silico (A). The POPE/POPG ratio of the lipids within 4 Å from 
the peptides is compared across the three peptides where a ratio lower than three indicates the peptide tends to 
cluster the anionic lipids. Temporin B and temporin B KKG6A show a higher clustering effect. AMP disordering 
effect on lipid membranes in the steady-state, as obtained from 2H solid-state NMR experiments (B–D). The 
effect of 2 mol% of each AMP was studied in multilamellar vesicles (MLVs) composed of POPE/POPG-d31 
(75:25) (B), POPE/POPE-d31/POPG (50:25:25) (C) or POPG/POPG-d31 (75:25) (D) in 5 mM Tris-amine 
buffer, pH 7.00 and 100 mM NaCl.
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remains resilient and either does not break (Fig. 7C) or takes significantly longer (p < 0.05) to break than when 
challenged with much less temporin B (Fig. 7D).
Discussion
Time-resolved techniques distinguish mechanistic features between the three temporin B pep-
tides. Here we investigated whether a combined biophysical approach is capable of discriminating the species 
specific antibacterial mechanisms of action between three analogues of temporin B. Although structures for the 
three peptides solved in anionic SDS were noticeably different, when applied to model membranes, little differ-
ence in conformation could be discerned in the steady-state. To address this, we developed an approach using 
the Port-a-Patch® tool from Nanion Technologies (Munich, Germany) and correlated the findings obtained from 
patch-clamp analysis to the primary sequence and the biophysical behaviour of the peptides. Notably, these two 
time-resolved techniques were better able to distinguish the activity of the temporin B analogues. The time course 
of AMP action is increasingly recognized as an important parameter and it is notable that the time taken for 
membrane conductance to appear in model membranes is consistent with the time taken for the attack of AMPs 
on bacteria reported elsewhere70,71. Although the pharmacodynamics of differing peptides will be variable, the 
latency associated with membrane activity of between 10 and 20 minutes for temporin B analogues is consistent 
with permeabilization of the E. coli cytoplasmic membrane70 and the induction of oxidative stress71 by LL-37 after 
around 25 minutes, well after bacterial growth has halted. Although recent MD simulation studies of the behavior 
of multiple AMPs binding to membranes in systems of comparable size explore up to 800 ns46, it is not possible to 
sample timescales required to understand this latency using all-atom molecular dynamics simulations. Instead, 
the MD simulations here describe the initial binding of the temporin B analogues to model bilayers − 100 ns is 
sufficient to sample a period in which a local minimum is attained46 - and succeed in discriminating different 
binding and insertion which can be directly related to the differences in primary sequence.
The study of membrane active molecules, such as AMPs, with electrophysiology is complicated by their irreg-
ular activity when interacting with the bilayers. Indeed, only few AMPs apparently form regular single-channels 
when analysed with this technique58–60, while many show irregular membrane activity which is hard to define58,72. 
Nevertheless, a rationale has been suggested in order to distinguish between the “barrel-stave”, “toroidal” pores 
or “carpet-like” mechanisms on the base of the current traces57. Events showing a single-channel nature would 
characterise a pore, while an irregular current trace would be representative of a carpet mechanism. Moreover the 
different mechanisms could be distinguished on the basis of shorter or longer time constants of current activation 
and recovery, indicating a “barrel-stave” or a “toroidal” pore, respectively, and the irreversibility of the permea-
bilization process that would be the signature of a “carpet” like mechanism (detergent-like)57,61. This character-
isation is based on the predominant models currently used to describe AMPs activity1,7. However, more recent 
studies indicate many events at the bacterial plasma membranes are poorly described by these existing models 
Figure 6. Membrane activity of the temporin B analogues. Representative current traces and all-points 
histograms for temporin B (A,B), temporin B L1FK (C,D) and temporin B KKG6A (E,F) in DPhPE/DPhPG 
(A,C,E) or DPhPG (B,D,F) membranes. Experiments were acquired with a holding potential of +50 mV and in 
the presence of 250 mM KCl, 50 mM MgCl2, 10 mM HEPES, pH 7.0. Y-axis is scaled accordingly to the different 
amplitudes for the different peptides.
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and refinements or entirely new models are required to satisfactorily explain the behaviour of some AMPs; for 
instance the “snorkelling mechanism”73,74, the “dynamic peptide-lipid supramolecular pore”72,75–77 or the “disor-
dered toroidal pore”44,52,78. Informed by molecular level information provided by MD simulations, the substantial 
changes in membrane activity amongst the three temporin B analogues are discussed below and indicate that 
relatively minor modifications of the primary sequence can cause substantial shifts between behaviours associated 
with each of the models described above.
Temporin B is a hydrophobic AMP, prone to self-association. Temporin B and its two analogues 
are poorly studied, and little information is known about their mode of action. Hydrophobic AMPs such as tem-
porin B have been proposed to go through an aggregation process and form fibrils as a step in the bactericidal 
process79. As with amyloid peptides, this mechanism would form a cytotoxic intermediate which would cause the 
death of the cell (bacterial in this case) through poration of the plasma membrane. Evidence is indeed provided 
here for substantial aggregation of temporin B and its analogues but there is no evidence of any conformational 
shift, from α-helix to β-sheet, as characteristic of amyloid-like peptides as was predicted79. A self-association of 
temporin B monomers through hydrophobic interactions was also reported on lipopolysaccharide39,80; this was 
suggested to be the cause of the poor activity of this peptide against Gram-negative bacteria. Further, an increase 
in activity was observed for temporin B when used in combination with temporin L with the latter reported to 
inhibit the self-association. Presumably, temporin L can stabilise the monomer conformation of temporin B and/
or cause structural changes in lipopolysaccharide when bound, which prevents temporin B aggregation. When 
in combination, the two peptides showed a higher potency in lipopolysaccharide disintegration13,39,80. Primary 
sequence modification strategies that seek to reduce self-association of temporin B may therefore enhance its 
activity against Gram-negative bacteria.
Modification of the temporin B primary sequence to create temporin B L1FK. Temporin B L1FK 
was computationally designed with a statistical model considering the cytotoxicity of the sequence, but also a close 
physicochemical pattern to the parent peptide16. Temporin B L1FK behaves similarly to temporin B in inducing 
conductance albeit with a greater number of channel-like events and at somewhat lower concentrations and 
this correlates with the improved potency obtained against both Gram-negative and Gram-positive bacteria. We 
ascribe this improvement in membrane activity, and consequently in anti-bacterial potency, to increased inser-
tion into the membrane associated with reduced self-association. This is achieved with greater hydrophobicity 
Figure 7. Latency and duration of membrane activity. The average time elapsed between peptide addition 
and the first appearance of membrane activity (A,B) and the average duration of activity before the membrane 
breaks (C,D) is shown for DPhPE/DPhPG (A,C) and DPhPG (B,D) membranes.
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at the N-terminus by substituting phenylalanine for leucine, the increased positive charge and the reduced con-
formational flexibility between residues six and eight. For both temporin B and temporin B L1FK, patch-clamp 
revealed no difference in activity according to membrane composition. In neither case could the observed activity 
be defined as regular single-channel formation, but rather a perturbation of the permeability of the membrane 
due to defects of the lipid bilayer that cause spikes of current. Unlike temporin B, temporin B L1FK, in addition to 
the spikes also caused some square-shaped events resembling channels or pores but characterized by disordered 
openings in which an uneven distribution of levels can be detected. Such conductance activity is well removed 
from that reported for “barrel-stave” or “toroidal” pores, as described previously for alamethicin, gramicidin A, 
cecropin B and dermicidin58–60. Instead, the current traces obtained for both temporin B and temporin B L1FK 
are comparable to the ones obtained for gramicidin S58, for which they suggest a mechanism similar to the so 
called “in-plane diffusion” model81,82. In this model the peptides insert into the phospholipid bilayer disordering 
the packing and causing defects that can increase the membrane permeability. However, in this model the aggre-
gation of peptides is considered minimal and unfavourable, while we observed considerable self-association for 
temporin B and, although reduced, also temporin B L1FK. The immediate membrane rupture observed for tem-
porin B in all the electrophysiology measurements is consistent with the “carpet-like” mechanism, where peptides 
disintegrate the membrane following a detergent-like process61,83. However, such behaviour was not observed for 
temporin B L1FK. Current traces similar to those obtained for temporin B L1FK, characterised by abrupt tran-
sient current spikes, were reported for poly-arginine peptides, known to act as cell-penetrating peptides (CPP)84. 
The deep and flat insertion, observed for this temporin B during the MD simulations, might suggest the ability 
of this peptide to better penetrate the bilayer and act inside the cell – activity not captured by techniques applied 
in the present study.
Modification of the temporin B primary sequence to create temporin B KKG6A. Modification 
of temporin B through addition of two lysines at the N-terminus and replacement of a glycine with an ala-
nine ensures that self-association of the resulting peptide, temporin B KKG6A, is substantially reduced. This is 
achieved though at cost of preventing insertion of the peptide, beyond the first two residues at the N-terminus, 
into either membrane and a very large increase in the amount of peptide required to obtain any conductance 
activity. This is a reminder that not only the net charge, but also its distribution along the sequence is impor-
tant for AMPs activity78,85. However, while this might explain the loss of activity against Gram-positive bacteria, 
activity against E. coli was actually improved compared to the original temporin B peptide. Notably however, 
and in contrast to temporin B and temporin B L1FK that disorder the anionic phosphatidylglycerol component, 
temporin B KKG6A disorders the zwitterionic phosphatidylethanolamine component of membranes designed 
to mimic the plasma membrane of Gram-negative bacteria. This, together with a clear interaction with the head-
group region of the phospholipid bilayer observed in the MD simulations, suggests that the peptide is interacting 
with the membrane, but that the effect of this interaction does not readily induce channel conductance detectable 
through patch-clamp. The disorder observed in phosphatidylethanolamine lipids is related to the observation, in 
MD simulations, that temporin B KKG6A is particularly effective at clustering anionic lipids. This can be toxic to 
bacteria by disrupting membrane domains essential for specific interactions with other molecules86 and might not 
cause a leakage visible with techniques as patch-clamp. Adoption of this mechanism against E. coli is consistent 
with the loss of activity against Gram-positive species, the plasma membrane of which is mainly composed of 
negatively charged lipids65–69. Whether this or other mechanisms more accurately describe the behaviour and 
anti-bacterial activity of temporin B KKG6A, it is clear that, following the optimization process, its mechanism of 
action differs substantially from the native temporin B peptide.
Conclusion
Since cecropin, the first AMP, was isolated from the hemolymph of the silk moth Hyalophora cecropia in 198187, 
AMPs have been studied as a new interesting class of molecules for the development of new antibiotics. The 
attraction of these short, cationic peptides is related to their ability to defeat infections from many different path-
ogens (bacteria, fungi, viruses) and, in particular, the low rate of bacterial resistance onset1–3,6. Despite the efforts 
made to characterize different AMPs from different sources, there is still a lack of understanding of their spe-
cific modes of action and variation thereof due to sequence modifications1. The activity of temporin B is likely 
improved in vivo through its synergistic interaction with temporin L which acts to prevent self-association. Both 
sequence modification strategies described here also act to reduce self-association of the AMP in the target mem-
brane but lead to fundamentally different behaviour which was revealed by a combination of MD simulations and 
patch-clamp conductance recordings but not by e.g. circular dichroism. Therefore, in characterising the mem-
brane interaction of temporin B and its analogues, the present study shows that even minor alterations to AMP 
primary sequences may cause drastic changes in the mechanism of interaction with bacterial plasma membranes 
which in turn affect antibacterial potency and selectivity. Future attempts to enhance the potency of designed 
or naturally occurring AMP sequences will be aided by as sophisticated as possible understanding of the crucial 
peptide-peptide and peptide-membrane interactions and their outcomes.
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